Zobrazeno 1 - 4
of 4
pro vyhledávání: '"E J, Abbink"'
Autor:
A, Rutte, S P, Rauh, M T, Schram, G, Nijpels, J H, DeVries, F, Holleman, H, Pijl, O M, Dekkers, B, Özcan, E J G, Sijbrands, C J, Tack, E J, Abbink, H W, de Valk, B, Silvius, B H R, Wolffenbuttel, C D A, Stehouwer, N C, Schaper, J M, Dekker, J W, Beulens, P J M, Elders, F, Rutters
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 34(11)
Individual indicators of socio-economic status have been associated with glycaemic control in people with Type 2 diabetes, but little is known about the association between partner's socio-economic status and HbAWe included people with Type 2 diabete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a960db39d441e166c42fb97431062698
https://pubmed.ncbi.nlm.nih.gov/28703888
https://pubmed.ncbi.nlm.nih.gov/28703888
Publikováno v:
Diabetes, obesitymetabolism. 15(1)
We recently showed in a euglycaemic glucose clamp study among 18 healthy volunteers that using jet injectors rather than conventional pens significantly improved the time-action profiles of rapid-acting insulin analogs. Here, we investigated whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3638739e51bd1dc90543177f90f30e28
https://pubmed.ncbi.nlm.nih.gov/22830987
https://pubmed.ncbi.nlm.nih.gov/22830987
Autor:
E J, Abbink, P, Pickkers, A, Jansen van Rosendaal, J A, Lutterman, C J, Tack, F G M, Russel, P, Smits
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 19(2)
Glibenclamide attenuates the protective responses to opening of vascular ATP-sensitive potassium (K(ATP)) channels during ischaemia. Therefore, glibenclamide treatment of Type 2 diabetes mellitus may have hazardous cardiovascular effects when used un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::140ad886dd9c9d2815644cd0a6762689
https://pubmed.ncbi.nlm.nih.gov/11874430
https://pubmed.ncbi.nlm.nih.gov/11874430
Autor:
E J, Abbink, P, Pickkers, A Jansen, van Rosendaal, J A, Lutterman, C J, Tack, F G M, Russel, P, Smits
Publikováno v:
Clinical science (London, England : 1979). 102(3)
Glibenclamide inhibits the opening of vascular ATP-sensitive potassium (K(ATP)) channels, which represents a protective mechanism during ischaemia. This effect may imply harmful cardiovascular effects of glibenclamide when used under conditions of is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1d60b0601d4b6bf4207b5ddf6945eb8d
https://pubmed.ncbi.nlm.nih.gov/11869171
https://pubmed.ncbi.nlm.nih.gov/11869171